Family context
Product NDC 50242-0214 groups closely related presentations under the same catalog family, giving healthcare teams a clearer path for comparing packaging and alternate exact NDC rows before an RFQ is submitted.
- Family size: 6 active presentations.
- Generic family: omalizumab.
- Primary dosage form: Injection.
- Common strength: 75 mg / .5mL.
What changes inside this family
Use the family page to compare formats, then click into the exact NDC page that matches the package your team needs.
- Manufacturers shown: Genentech, Inc..
- Dosage forms shown: Injection.
- Package quantities: 1 Syringe, Glass.